Abstract
Vaccination is a key public health intervention, and Muslims who comprise a quarter of the world’s population, have shown mixed responses to it. Previous research has addressed Islamic perspectives on vaccination but understanding its efficacy from secular and religious points of view across Islamic countries is limited. This narrative review utilised database search (Google Scholar, PubMed, Scopus, SSRN, and Web of Science) followed by curation based on expert knowledge. It offers theological and technological insights, and the potential impacts of climate change on vaccination in Islamic countries. Though Islamic teachings support vaccination, hesitancy results from a complex mixture of sociological and technological barriers that include misinformation, lack of trust, poor living conditions, and vaccine inequity in resource-limited communities. Climate change will act as a threat multiplier, particularly in areas inhabited by over 80 percent of the world’s Muslims. Successful approaches from Islamic countries highlight the role of cultural and religious perspectives, infrastructure, and biological factors on the coverage and efficacy of childhood, adolescent and adult vaccines. The learnings offer strategies to improve vaccination everywhere, but particularly in Muslim populations.
Introduction
Vaccination is an important public health intervention, which has halved child mortality, saved an estimated 154 million lives in the last 50 years [, ], and continues to prevent about 4.4 million deaths annually []. Vaccines also reduce poverty by limiting out-of-pocket medical expenditure, increase literacy by keeping children in school, decrease the use of antibiotics, and reduce the impact of pathogen spillovers which may be aggravated by climate change []. However, these can only be achieved if vaccines reach large swathes of the population, which relies on efficient healthcare systems and the willingness to be vaccinated. Consequently, successful vaccination campaigns also include cultural sensitivity in their messaging, planning and implementation.
The Organisation of Islamic Cooperation (OIC) includes 57 countries with either a majority or a significant Muslim population [] that are heterogenous by way of economic, political, cultural and regional diversity. As Muslims constitute about a quarter of the world population, predicted to reach about 30 percent by 2050 [], understanding their socio-cultural and religious attitudes to vaccination is important. Due to complacency, conflicts, mistrust, and misunderstood religious positions on vaccination, the only countries where polio remains endemic, are both Islamic (Afghanistan and Pakistan). Some recent vaccines are also used less commonly in Islamic countries. The Vaccine Confidence Project surveyed over 280,000 people from 149 countries between 2015 and 2019 []. Its findings show declining confidence in vaccines in six countries–Afghanistan, Azerbaijan, Indonesia, Nigeria, Pakistan and Serbia–five of which are OIC member countries.
In this narrative review we provide a broad, interpretive summary of vaccination in Islamic countries and examine it through the lens of religious guidance on health and wellbeing. It will revisit the challenges and barriers to vaccination faced by low-and-middle-income countries (LMICs), particularly under the impacts of climate change, with an emphasis on Muslim societies. With success stories and best practices, we explore how to lower barriers and overcome challenges.
Overview of vaccination in Islamic countries
Vaccination across Muslim-majority countries is uneven, shaped less by religion than by state capacity, conflict, financing, public trust and health-system reach. The diphtheria-tetanus toxoid-pertussis vaccine (DTP3) involves three doses and is a good indicator of access to vaccination services []. The mean of one-year-olds immunised with DTP3 is 83.6 percent for OIC countries and 87.3 percent for others. The rotavirus and pneumococcal vaccines introduced around the year 2000 have an estimated coverage of 78 percent and 80 percent respectively in OIC countries, against the global average of 76 percent and 83 percent []. But for the newly developed COVID-19 vaccine, only 50.8 percent of people in OIC countries had received at least one dose by 2022, compared to 64.3 percent globally [].
The association between per capita GDP of OIC countries and their DTP3 and COVID-19 vaccine coverage is shown in Figure 1. The established DTP3 childhood vaccine has better coverage compared to the adult and emergency use COVID-19 vaccine. Notably, the same countries are found above or below the median for both DTP3 and COVID-19 vaccinations, indicating why robust in-country vaccination infrastructure is important in countering emerging health threats. The new COVID-19 vaccines developed during the pandemic were expensive and in short supply []. Understandably, the correlation between vaccine coverage and per capita GDP is better for the COVID-19 vaccine compared to the DTP3 vaccine, which is now routinely available to low- and low-and-middle-income countries.
FIGURE 1
Funding is a key driver of inter-country variation in vaccination rates. In LMICs the government contributes 63.2 percent of vaccination spending, with 30.4 percent coming from development assistance agencies such as the Global Alliance for Vaccines and Immunization (GAVI) []. Contributions from the private sector, non-governmental organisations, faith-based organisations and for-profit clinics, vary considerably across settings [].
Islamic perspectives on vaccination
Theological position on vaccination
According to Dar Al-Ifta, an Egyptian Islamic advisory, justiciary and governmental body – “In Islam, the sanctity of life is an inherent right for every human being because life is a God-given gift and a manifestation of His Divine grace” []. This line of reasoning, which also follows from earlier Abrahamic traditions, is used to interpret theological support for vaccination in Islam. For example, when asked if it was a sin to not seek treatment, the Prophet Mohammad (peace be upon him) is reported as saying, “Seek treatment, O slaves of Allah! For Allah does not create any disease but He also creates with it the cure, except for old age” []. There is a consensus among Islamic scholars that seeking vaccination is a religious duty because not doing so may lead to transmission of the disease to others and affect the community’s wellbeing [].
Vaccine concerns among Muslims
Despite clear theological guidance, misconceptions related to vaccines exist among some Muslims. A survey in Guinea found that 54 percent of common people and 20 percent of religious leaders considered vaccination to be prohibited during the month of Ramadan []. However, several religious authorities and organisations, including the President of the General Presidency for the Affairs of the two Holy Mosques in Saudi Arabia have issued statements that receiving a vaccine does not invalidate the Ramadan fast [].
Another common concern is that vaccine preparations may contain haram (or prohibited) ingredients, such as the enzyme trypsin, which is isolated from pig pancreas and is used in the production process for some vaccines. Even when trypsin is used, the World Health Organization (WHO) and European Medicines Agency certify it to be absent from the vaccine product []. In 2018, Indonesia’s Central Ulama Council issued a fatwa (opinion) declaring that the measles-rubella vaccine had porcine ingredients, but vaccination was still permissible due to its public health benefits []. Such mixed messaging confused local clerics and parents, and vaccination rates declined to 8 percent in some provinces []. The WHO and religious leaders have used the principle of istihala–that chemical reactions lead to loss of the original form–to declare such vaccines to be halal (permissible). Recombinant trypsin produced in bacteria or yeasts is now increasingly being used for vaccine and biopharmaceutical manufacturing, negating this concern [, ].
While core Islamic concepts support vaccination, the reasons for hesitancy are complex and include social and religious beliefs []. In the USA, Muslims showed a higher intent to be vaccinated than the general population, and in Saudi Arabia vaccine hesitancy decreased with increasing education and income []. Misinformation and low trust in government contribute to vaccine hesitancy everywhere, including among Muslims.
Challenges and barriers to vaccination
Vaccination faces both technological and sociological barriers. The former includes vaccine research and development, its production, distribution, and real-world effectiveness. The latter include reduced acceptance due to poor understanding of vaccine science and negative social media messaging, including false claims of links to autism and injury.
Production of vaccines
Vaccine production is a natural monopoly since scale is needed to ensure affordability, but this reduces equity, especially for new vaccines and in outbreak situations. The production of COVID-19 vaccines was restricted to the US, Europe, China and India–where more than ninety percent of all doses were manufactured []. Large parts of the world, including most of Africa, Asia and Latin America, did not produce any of these vaccines. Africa produces less than one percent of its routine vaccines, and produced no COVID-19 vaccines, which correlates with low vaccine uptake across the continent (Figure 2).
FIGURE 2
Very few vaccine manufacturing sites exist in LMICs and Islamic countries. Iran, Kazakhstan and UAE were the only OIC countries to manufacture any type of a COVID-19 vaccine during the pandemic. Indonesia has good infrastructure for producing polio and other childhood vaccines and has set up a partnership for future pandemic vaccines []. Pakistan purchased a Chinese COVID-19 vaccine in bulk and repackaged it for domestic use []. However, none of these countries produced sufficient doses to even fulfil domestic requirements []. Iran (population 91 million) produced 15 million doses [] and used over 155 million doses []. Kazakhstan (population 20.5 million) produced 9.6 million doses [] and used 26 million doses []. Other OIC countries and LMICs imported COVID-19 vaccines when supplies were limited. Unsurprisingly, a country’s per capita GDP correlated well with its COVID-19 vaccine uptake [, ], except for India, which has invested in vaccine production for domestic use and export.
Vaccine supply chains
Getting vaccines to the populations that need them is critical, but areas under conflict present a significant challenge. Four of the six countries with less than 50 percent DTP3 coverage are affected by conflict, and three of these are OIC member states (Guinea, Yemen and Somalia) [, ]. Conflict zones also have compromised health systems, but vaccination programmes are particularly vulnerable as their impact is not immediately visible. The destruction of hospitals and healthcare facilities, collapsed sanitation systems, overcrowded refugee camps, and the lack of access to clean water in Gaza, brought back wild type poliovirus to this region in 2024 since its polio-free status in 1999 []. A ceasefire enabled three rounds of polio vaccination campaigns between September 2024 and February 2025 to urgently address the problem [].
Vaccine wastage is yet another challenge. The US Food and Drug Administration has approved 98 vaccines, of which about 70 percent are liquids stored at 2 °C–8 °C with expiration dates ranging from 4 months to 3 years []. About 20 percent of the vaccines are freeze-dried powders stored at 2 °C–8 °C, and the rest are frozen liquids. If the frozen vaccines are thawed, the liquid ones inadvertently frozen, or the lyophilized powders not used within a few hours of rehydration, the vaccines are discarded. Nearly 50 percent of vaccines are wasted globally due to improper cold chain [] and availability in multi-dose vials [].
Cold chain also presents a significant challenge for LMICs with unstable power supplies []. Bad roads and hard to reach areas make it even more difficult to deliver vaccines to needy populations. But these problems have also attracted novel approaches and disruptive innovation. Solar refrigerators that connect directly to solar panels, instead of relying on an unstable power grid or backup batteries, can keep vaccines at the right temperature []. In hard to reach areas, biker teams have distributed polio drops to nomadic settlements in Afghanistan [], and drones are being used in Africa to deliver vaccines, essential drugs and blood supplies to remote areas []. Administering vaccines requires good infrastructure including clinics, healthcare workers and documentation systems. Several studies highlight logistical barriers that deter families that are otherwise accepting of vaccines [, ]. One survey of families in Pakistan where children had not received the polio vaccine found the absence of visits by vaccination teams to be the most common reason for it []. The density of vaccination workers correlates with immunisation coverage for several other vaccines [].
Vaccine acceptance
Vaccine refusal among Muslims is another barrier, a common concern being the perceived haram status of certain vaccines []. Conspiracy theories and the belief that polio vaccines will lead to infertility in Muslim children have reduced its acceptance in Nigeria [43] and Pakistan [44]. In 2007, Sudan’s Muslim Brotherhood issued a fatwa against all vaccines on the unfounded claim of being the conspiracy of Jews and Freemasons []. Often these theories arise from a lack of trust in the state’s intentions []. Given the legacy of disease research on vulnerable populations, and the use of vaccination programmes to achieve political goals, these concerns cannot be ignored. The Tuskegee Syphilis Study on black men, and the deliberate infection of intellectually challenged children at Willowbrook State School to understand the aetiology of viral hepatitis, are examples of the painful legacy of vaccine development [45, 46]. The US Central Intelligence Agency’s fake vaccination programme in 2011 to track Osama bin Laden is another act that reduced trust and set back polio eradication in Pakistan and Afghanistan [47]. In January 2021, when COVID-19 cases were rapidly rising in Iran [48], its leaders ruled out importing vaccines from either USA or UK due to their mistrust of the West. A 2023 modelling study estimated that earlier vaccination of vulnerable groups in Iran could have prevented over 75,000 deaths during the first two years of COVID-19 [49].
Vaccine effectiveness
The immune response to vaccines is variable, with some oral vaccines being less effective in resource poor settings [50, 51]. The reasons are complex, including malnourishment and enteric infections, which impair T-cell memory responses [52]. Gastrointestinal infections worsen a child’s ability to absorb nutrients, leading to a vicious cycle of undernourishment, immunosuppression and increased susceptibility to vaccine preventable diseases [53]. Campylobacter and enterovirus infections decrease the protection offered by oral vaccines against polio and rotavirus diarrhoea [54, 55]. Such enteric infections are more common in areas without access to safe water and disproportionately affect low-income countries. Islamic countries show slightly more under-nourishment (13 percent) compared to others (10 percent). They also have higher mortality (18.2 per 100,000 people) that is attributed to unsafe water, compared to others (10.1 per 100,000 people) [56]. As reduced vaccine effectiveness increases hesitancy in societies that need them the most, nutrition-focussed interventions and improvements to personal and community hygiene are as important but have received insufficient attention.
Digital misinformation
Digital misinformation circulates in many Islamic countries, just as it does elsewhere. Common narratives including non-halal ingredients, links to infertility, foreign conspiracies, and concealment of dangerous side effects have appeared against polio, measles and COVID-19 vaccines. Research shows that social media platforms have enabled rapid dissemination of vaccine misinformation globally, including in low- and middle-income Muslim-majority countries. The most effective approaches to counter these include engagement with trusted religious leaders and public endorsements from Islamic scholars; transparency of vaccine ingredients and halal certification; community-based instead of top-down communications; monitoring and rapid response to misinformation; and building trust in institutions [57].
Climate change and vaccination
There is now increasing attention to the impacts of climate change on human health. About 60 percent of human pathogens are estimated to be aggravated by climate hazards, making preparedness, including the development of new vaccines, a priority [58, 59]. This is especially relevant for Muslim societies since over 80 percent of the world’s Muslims live in areas most prone to climate change.
Impact on disease transmission
Environmental threats are projected to cause animal and human migration into new areas, resulting in novel interactions between mammalian species, and an estimated 4,000 new episodes of cross-species virus transmission [60]. Most virus-sharing events are predicted for the Indian subcontinent, Sahel, and Southeast Asia. These areas also have large Muslim populations.
Changing pathogen distribution will also impact regional vaccine requirements. Insect vectors will multiply faster because of rising temperatures and longer monsoons [61], exacerbating vector-borne diseases, an example being the worst ever dengue outbreak in Bangladesh in 2023 [58]. Malaria transmission has already gone up in two- to ten-year-olds in Sub-Saharan Africa [62]. Plasmodium falciparum, the most dangerous form of malaria, is transmitted by the Anopheles gambiae mosquito that propagates best at 25 °C. With rising temperatures its distribution might shift from Sub-Saharan to Southern or Eastern Africa [61]. The Aedes aegypti mosquito transmits several viruses including the dengue virus, multiplies best at 29 °C, and its global spread is increasing. Though new malaria vaccines have recently become available, endemic countries cannot afford these at about $10 per child [63].
It is estimated that by 2050 over 5 billion people will be exposed to at least 1 month of extreme heat annually, with several countries in Asia, the Middle East and Africa having already crossed that threshold [64]. Erratic water patterns will damage sanitation systems and push people to use unsafe water, increasing the transmission of waterborne diseases [61]. Extreme heat is also associated with increased infectious diarrhoea caused by bacteria such as Salmonella and Shigella, which manipulate the host’s metabolism and lower immunity [65]. Heat and changing vector patterns will necessitate changes in national immunisation programmes, and emergency vaccination in the affected areas.
Impact on vaccine delivery
Extreme weather events such as floods reduce access, especially for people in rural and hard to reach places [59]. Increasing heat reduces attendance at health facilities and affects routine immunisation services due to the breakdown of cold chain equipment. Climate change will cause population displacement, making it harder for immunisation services to track people and provide routine vaccinations [59]. Further, the areas that climate refugees are displaced into may not have adequate health infrastructure to provide routine care to rapidly increasing populations [58].
Impact on vaccine effectiveness
Climate change is predicted to reduce crop yields, increasing cereal prices and worsening malnutrition, with stunting expected to rise by 23 percent in Sub-Saharan Africa and 62 percent in South Asia [66]. These regions are also home to about 50 percent of the world’s Muslims, who are largely poor. Reduced access to food and other resources will cause population displacement, with people moving into informal housing with poor sanitation, further exposing them to enteric infections [59, 66]. Climate-related extreme weather increases air pollution, reduces biodiversity, and causes psychological stress, all of which lower immunity [66, 67]. Since undernutrition and stress decrease vaccine-derived immunity and increase susceptibility to infections, it would be even more important to expand immunisation programmes to underserved populations.
Success stories and best practices
To improve vaccination, it is instructive to learn from successful examples from the Muslim world. We highlight smallpox and polio eradication programmes, and Islamic countries that have vaccinated their populations beyond their socioeconomic status and the prevailing religious environment.
Smallpox eradication
For centuries smallpox remained a major cause of morbidity and mortality, killing an estimated 300–500 million people in just the 20th century [68]. Though modern vaccination is attributed to Edward Jenner, who in 1796 used cowpox to protect against smallpox, variolation was widely practised in the Orient and was brought to England in the early 18th century [69].
Within the Islamic world, the contributions of the Ottomans to smallpox control are particularly noteworthy [70]. Sultan Abdulmejid I (ruled 1839–1861) built medical research institutions, provided free vaccination and published the treatise Menafiu’l-etfal (Benefits to Children) to dispel common myths. Similar efforts were undertaken by Muhammad Ali (ruled 1805–1849) in Egypt and Crete [70]. In 1967, the World Health Organization launched an intensified plan to eliminate smallpox, culminating in its eradication in 1980 – the only infectious disease affecting humans to be eradicated [71]. The lack of animal reservoirs for smallpox, the existence of a heat-stable single-dose vaccine, intensive surveillance to identify new cases, and ring vaccination of contacts were important for its eradication [72, 73]. Proper training and supervision of minimally educated volunteers [72], good tools and logistics and gaining the trust of key stakeholders, are important lessons from smallpox eradication.
Towards polio eradication
The global vaccination campaign against poliovirus is another success, with the wildtype virus currently endemic only in Afghanistan and Pakistan []. Efforts in these countries have successfully reduced vaccine hesitancy by involving influential people and religious leaders []. In areas with high rates of vaccine refusal, vaccinators carry fatwa pamphlets with endorsements from Islamic scholars [74] and religious leaders have delivered pro-vaccine sermons []. The female mobiliser vaccine network in Afghanistan, which includes local women, has helped vaccinate hard-to-reach children through health education sessions, access to mothers, and providing vaccines in their local communities [75].
Many under-immunised children are also under-nourished, reinforcing the importance of a public health strategy that integrates nutrition and immunisation services. For example, vitamin A deficiency being widespread, it is given with the oral polio vaccine on national immunisation days [76]. Free school meals are available to 41 percent of primary school children worldwide, but to only 18 percent of children in low-income countries [77], which deserves urgent attention.
Vaccination in Bangladesh
Bangladesh’s routine vaccination rates are better than countries of comparable per capita GDP – 98 percent DTP3 coverage for one-year-olds, and 89 percent of the population received at least one dose of a COVID-19 vaccine []. Public opinion in Bangladesh favours vaccination, with 99 percent agreeing that vaccines are safe [78]. During the pandemic, social media updates increased public awareness and vaccine demand [79]. Bangladesh received NGO support for over half of its routine immunisation services [80] and had the most COVID-19 vaccine donations from COVAX, China and India [79]. Reducing out-of-pocket expenditure, and structural improvements such as a digital District Health Information System that records all vaccinations, made it easier to identify under-performing areas for targeted action, and increased the efficiency of vaccine administration [80]. The lessons from Bangladesh include the importance of public understanding of vaccination, the role of NGOs, and effective technologies supporting national immunisation programmes.
Cervical cancer vaccination in Malaysia and Uzbekistan
Cervical cancer, caused by the human papilloma virus (HPV), is the second leading cause of cancer deaths among women in less developed countries [81]. Islamic countries have lower rates of HPV infection due to conservative sexual behaviours, but poor screening makes it difficult to quantify prevalence and changing trends [81]. Three OIC countries–Mozambique, The Comoros and Guyana–have a particularly high burden of cervical cancer [82]. The HPV vaccine given during adolescence is routinely used in only 20 of 57 OIC countries compared to around three-quarters of other countries [83]. But OIC countries that use the HPV vaccine have population coverage like other countries [84], suggesting that a vaccine is accepted once it is included in the programme. Fewer Muslim countries mandating its use could be due to a reluctance to discuss sexual health, or the perception that consent to vaccinate encourages sexual activity [85].
Malaysia follows a school-based HPV programme that has high parental consent and 95 percent vaccination of eligible schoolgirls [86]. In Uzbekistan 94 percent of 12–14-year-old girls have received the first dose of an HPV vaccine [87]. Such high rates are due to clear communication with messaging focused on maternal health and protecting motherhood rather sexual health [87]. Good communications, data transparency, and promptly addressing misinformation are key to these successes. Other OIC countries such as Bangladesh, Nigeria and Togo are following this successful model [88].
The GCC countries
The Gulf Cooperation Council countries had some of the highest COVID-19 vaccine uptake globally due to strong government leadership (vaccine procurement, free vaccination), good digital infrastructure, and healthcare access. Studies in the region show that while COVID-19 vaccine acceptance was high due to an immediate threat perception, HPV vaccination faces challenges related to awareness, perceived risk, and cultural sensitivities. Other than Abu Dhabi, which has >95% HPV vaccine uptake through school-based programmes, the rest of the region shows <10% uptake [89]. Studies emphasize the importance of regional collaboration and long-term self-sufficiency through sustainable financing, local manufacturing to improve vaccine access and equitable outcomes across the Middle East [90].
Strategies for improving vaccination
There is a need to learn from success stories, include new strategies into existing programmes, and to be particularly mindful of adult vaccination to counter climate-related exacerbations of infectious diseases. Access to emergency vaccines remains a key barrier, especially for low-income countries and LMICs in Africa, Asia and Latin America.
Vaccine production
Vaccine manufacturing should be expanded globally to include more countries and regions. A 2023 study identified 43 countries, including 11 OIC member states, with the capacity to produce WHO pre-qualified vaccines [91]. Two OIC countries–Tunisia and Azerbaijan–are particularly strategic due to existing industrial capacity and small population size, allowing them to provide for their population and export to other countries [91]. Several other Islamic countries such as Kuwait, Oman, Qatar, the UAE and Brunei Darussalam have skilled manpower and sovereign wealth funds that can leverage investments for social good, and serve as good regional vaccine production hubs.
Africa’s population is expected to grow rapidly from 1.5 billion in 2024 to 3.8 billion by 2100 [92], of which 40 percent are Muslim. Africa also bears a disproportionate burden of infectious diseases with morbidity and mortality that hinders sustainable development. The continent’s experience with HIV/AIDS research could guide the development of new vaccines in Africa [93]. Vaccine R&D, innovation and intellectual property are presently concentrated largely in the global North. It will take political will, sustainable regional markets, and a strong regulatory environment to overcome these barriers [94]. The WHO Pandemic Treaty may help improve access to technology and improve vaccine equity [95].
Delivery of vaccines
Vaccine access is limited in remote areas with bad roads. Drones are being used to deliver vaccines, essential drugs, and blood supplies in these areas, with lower emissions compared to road transport [58, 96, 97]. Changes in vaccine provision, such as using polio immunisation days to administer other routine immunisations allow for the sharing of workers, facilities, and knowledge to improve all vaccinations. Providing nutritional support in schools, increases vaccine effectiveness and improves coverage and learning outcomes by reducing sick days and keeping children in school [76].
Making access more convenient improves vaccine uptake. India’s highly successful Pulse Polio Immunisation Programme uses advertising, neighbourhood camps and mobile teams to reach millions of children close to where they live [98]. In Uganda, accessibility was improved by advertising temporary National Immunisation Days within walking distance from home []. As global warming makes extreme heat more widespread, vaccination services will also have to adapt. In India, immunisation services are opening earlier in the day when it is cooler [59].
Vaccine acceptance
Vaccination is positively reinforced through culturally sensitive and community-centred campaigns that address people’s religious, cultural, and socioeconomic concerns. For Islamic countries, this includes the involvement of influential community and religious leaders in planning and implementation, and to encourage the devout to accept vaccines []. When endorsed by faith leaders, devout Muslims consider vaccination a religious obligation to promote health and preserve life and get vaccinated while observing the Ramadan fast. Communication plans that emphasise the safety, efficacy, and importance of vaccination in simple language dispel concerns and misinformation. Targeted outreach programs analogous to the female mobiliser networks in Afghanistan and school meetings in Uzbekistan can be used to address vaccine disparities within a region [75, 87].
Conclusion
Universal childhood immunisation rates in Islamic countries are as good as elsewhere, but some adolescent and adult emergency vaccines show reduced coverage. Despite the success of global polio eradication, the only two countries where wildtype poliovirus can still be found have predominantly Muslim populations. This results from misinformation and misrepresentation of theology. Technological and socio-economic factors such as the paucity of countries that can produce and deliver enough vaccines also contribute to reduced coverage.
Climate change will act as a threat multiplier, magnifying the difficulties in vaccinating populations in low income or hard-to-reach areas. It will reduce vaccine effectiveness and shape the types of vaccines required in the future. These problems are already apparent, and urgent action is needed to adapt and improve existing vaccination programmes.
To reduce inequity and improve access, vaccine production should be expanded to include a wider range of countries across different regions, with a focus on low and low-middle income countries. Novel approaches to vaccine delivery should be explored, with the use of emerging technologies or joining up vaccination with other interventions to provide holistic healthcare. Consultations with locally respected figures, and in many Muslim populations the endorsement of religious leaders is highly beneficial. Whilst the threats to vaccination in Islamic countries are multiple, progress has been made already, with millions of lives saved. Reflecting on the experience gained from the past and combining it with new technologies is a good recipe to prepare for emerging disease threats.
Being a narrative review, our work is limited by a lack of reproducible methodology for inclusion and exclusion, and may therefore be susceptible to selection bias, publication bias, and subjective interpretation.
Statements
Author contributions
A-OR surveyed published literature and online resources, wrote drafts and prepared the figures. SJ developed the plan, wrote drafts and finalised the manuscript. All authors contributed to the article and approved the submitted version.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The authors declared that they do not have any conflicts of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
References
1.
World Health Organization. Global immunization efforts have saved at least 154 million lives over the past 50 years (2024). Available online at: https://www.who.int/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years (Accessed May 6, 2025).
2.
World Health Organization. A brief history of vaccination. Available online at: https://www.who.int/news-room/spotlight/history-of-vaccination/a-brief-history-of-vaccination (Accessed May 6, 2025).
3.
UNICEF. Immunization. Available online at: https://data.unicef.org/topic/child-health/immunization/ (Accessed July 30, 2025).
4.
PecettaSNandiAWellerCHarrisVFletcherHScorzaFBet alVaccines for a sustainable planet. Sci Transl Med (2023) 15:eadf1093. 10.1126/scitranslmed.adf1093
5.
Member States. Organisation of islamic cooperation. Available online at: https://www.oic-oci.org/states/?lan=en (Accessed July 30, 2025).
6.
Pew Research Center. The future of world religions: population growth projections, 2010–2050 (2015). Available online at: https://www.pewresearch.org/religion/2015/04/02/religious-projections-2010-2050/ (Accessed July 30, 2025).
7.
de FigueiredoASimasCKarafillakisEPatersonPLarsonHJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet (2020) 396(10255):898–908. 10.1016/S0140-6736(20)31558-0
8.
World Health Organization. Diphtheria-tetanus-pertussis (DTP3) immunization coverage among 1 year olds (percent) (2024). Available online at: https://data.who.int/indicators/i/48D7D19/F8E084C (Accessed July 24, 2026, 2025).
9.
SpoonerFDattaniSVanderslottSRoserM. Vaccination. (2024). Available online at: https://ourworldindata.org/vaccination (Accessed July 24, 2026).
10.
Our World in Data. Share of people who received at least one dose of COVID-19 vaccine. Available online at: https://ourworldindata.org/grapher/share-people-vaccinated-covid (Accessed July 30, 2025).
11.
BasakPAbirTAl MamunAZainolNRKhanamMHaqueMR. A global study on the correlates of gross domestic product (GDP) and COVID-19 vaccine distribution. Vaccines (Basel) (2022) 10:266. 10.3390/vaccines10020266
12.
IkileziGMicahABachmeierSCogswellEMaddisonEStutzmanH. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–17: a financial modelling study. Lancet (2021) 398:1875–93. 10.1016/S0140-6736(21)01591-9
13.
SharmaGMorganCWanyoikeSKenyonSSheelMJainMet alPrivate sector engagement for immunisation programmes: a pragmatic scoping review of 25 years of evidence on good practice in low-income and middle-income countries. BMJ Glob Health (2024) 8:e014728. 10.1136/bmjgh-2023-014728
14.
Egypt’s Dar Al-Ifta. The right to life in Islam: a God-given gift?Available online at: https://www.dar-alifta.org/en/article/details/552/the-right-to-life-in-islam-a-god-given-gift (Accessed July 30, 2025).
15.
Ibn Majah. Sunan ibn majah 3436. Available online at: https://sunnah.com/ibnmajah:3436 (Accessed July 30, 2025).
16.
AlsuwaidiARHammadHAA-KElbaraziISheek-HusseinM. Vaccine hesitancy within the Muslim community: islamic faith and public health perspectives. Hum Vaccin Immunother (2023) 19:2190716. 10.1080/21645515.2023.2190716
17.
Peiffer-SmadjaNOuedraogoRD’OrtenzioECisséPNZeggianiZBeavouguiAHet alVaccination and blood sampling acceptability during Ramadan fasting month: a cross-sectional study in Conakry, Guinea. Vaccine (2017) 35:2569–74. 10.1016/j.vaccine.2017.03.068
18.
World Health Organization. Oral polio vaccine and its production. Available online at: https://www.emro.who.int/fr/polio/information-resources/oral-polio-vaccine-production.html (Accessed July 30, 2025).
19.
SudarsonoHIkawatiRKurniaAAzizahSNKholidMN. Effects of religiosity, halal knowledge and halal certification on the intention of Muslims to use the halal vaccine during Covid-19 pandemic. J Islam Mark (2023) 15:79–100. 10.1108/JIMA-06-2021-0179
20.
RochmyaningsihD. Indonesian fatwa causes immunization rates to drop. Science (2018) 362:628–9. 10.1126/science.362.6415.628
21.
VaidyaVAgnihotriSDhereRMuleyRPatilSPatilAet alUse of recombinant trypsin in production of vaccine against measles and rubella. Int J Curr Res (2016) 8(2):26136–41. Available online at: https://www.researchgate.net/publication/335737342 (Accessed July 24, 2026).
22.
Novo Nordisk PharmatecAS. Novo Nordisk Pharmatech Launches TrypsiNNex® (2024). Available online at: https://novonordiskpharmatech.com/novo-nordisk-pharmatech-launches-trypsinnex/ (Accessed July 30, 2025).
23.
Van GoghMHausmannLMohrDWolffC. Is the World up to the Challenge of Mass COVID-19 Vaccination?McKinsey & Company (2021). Available online at: https://www.mckinsey.com/industries/travel/our-insights/is-the-world-up-to-the-challenge-of-mass-covid-19-vaccination (Accessed July 24, 2026).
24.
Coalition of Epidemic Preparation Innovations. CEPI and Bio Farma partnership boosts rapid response vaccine manufacturing for the Global South (2023). Available online at: https://www.mckinsey.com/industries/travel/our-insights/is-the-world-up-to-the- challenge-of-mass-covid-19-vaccination (Accessed July 24, 2025).
25.
ShahzadA. Pakistan produces Chinese CanSinoBio COVID vaccine, brands it PakVac. Reuters (2021). Available online at: https://www.reuters.com/world/asia-pacific/pakistan-produces-chinese-cansinobio-covid-vaccine-brands-it-pakvac-2021-06-04/ (Accessed July 24, 2026).
26.
BarryD. Mapping Global Vaccine Production. Global Commission for Post-Pandemic Policy (2022). Available online at: https://globalcommissionforpostpandemicpolicy.org/covid-19-vaccine-production-to-january-31st-2022/index.html (Accessed July 24, 2026).
27.
Trading Economics. Iran: coronavirus vaccination total. Available online at: https://tradingeconomics.com/iran/coronavirus-vaccination-total (Accessed July 30, 2025).
28.
Wikipedia. COVID-19 vaccination in Kazakhstan (2025). Available online at: https://en.wikipedia.org/wiki/COVID-19_vaccination_in_Kazakhstan (Accessed July 30, 2025).
29.
Our World in Data. GDP per capita (2023). Available online at: https://ourworldindata.org/grapher/gdp-per-capita-worldbank (Accessed July 30, 2025).
30.
EzezikaOMengistuMOpokuEFarheenAChauhanABarrettK. What are the barriers and facilitators to polio vaccination and eradication programs? A systematic review. PLOS Glob Public Health (2022) 2:e0001283. 10.1371/journal.pgph.0001283
31.
Global Polio Eradication Initiative. Variant type 2 poliovirus isolated from sewage samples in Gaza (2024 Jul 19). Available online at: https://polioeradication.org/news/variant-type-2-poliovirus-isolated-from-sewage-samples-in-gaza/ (Accessed July 30, 2025).
32.
World Health Organization. Humanitarian access improves quality of polio vaccination campaign in the Gaza strip (2025). Available online at: https://www.who.int/news/item/28-02-2025-humanitarian-access-improves-quality-of-polio-vaccination-campaign-in-the-gaza-strip (Accessed June 21, 2026).
33.
United States Food and Drug Administration. Vaccines licensed for use in the United States (2025). Available online at: https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states (Accessed July 30, 2025).
34.
GuptaV. Why investing in cold chain technologies will improve health outcomes. Think Glob Health (2023). Available online at: https://www.thinkglobalhealth.org/article/why-investing-cold-chain-technologies-will-improve-health-outcomes (Accessed July 24, 2026).
35.
MvunduraMNgJReynoldsKNgYTBawaJBamboMet alVaccine wastage in Ghana, Mozambique, and Pakistan: an assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage. Vaccine (2023) 41:4158–69. 10.1016/j.vaccine.2023.05.033
36.
World Health Organization. Monitoring vaccine wastage at country levels – guidelines for programme managers (2005). Available online at: https://iris.who.int/handle/10665/68463 (Accessed July 30, 2025).
37.
Gates Foundation. How solar powered fridges are transforming vaccine storage in remote areas (2025). Available online at: https://www.gatesfoundation.org/ideas/articles/solar-power-vaccine-refrigerator (Accessed July 30, 2025).
38.
JafariH. 50 Years of Impact: How Polio Eradication and EPI Demonstrate what is Humanly Possible. Global Polio Eradication Initiative (2024). Available online at: https://polioeradication.org/news/50-years-of-impact-how-polio-eradication-and-epi-demonstrate-what-is-humanly-possible-through-collaboration-2/ (Accessed July 24, 2026).
39.
African Union Development Agency. Effective delivery of vaccines in Africa using drone technology (2023). Available online at: https://www.nepad.org/blog/effective-delivery-of-vaccines-africa-using-drone-technology#_ftn9 (Accessed July 30, 2025).
40.
SyirojATRPardosiJFHeywoodAE. Exploring parents’ reasons for incomplete childhood immunisation in Indonesia. Vaccine (2019) 37:6486–93. 10.1016/j.vaccine.2019.08.081
41.
HabibMATabassumFHussainIKhanTJSyedNShaheenFet alExploring knowledge and perceptions of polio disease and its immunization in polio high-risk areas of Pakistan. Vaccines (Basel) (2023) 11:1206. 10.3390/vaccines11071206
42.
HuYChenYWangYLiangHLvH. The association between the density of vaccination workers and immunization coverage in Zhejiang province, East China. Hum Vaccin Immunother (2021) 17:2319–25. 10.1080/21645515.2020.1865045
43.
MichaelCAOgbuanuIUStormsADOhuabunwoCJCorkum MAshenafiSet alAn assessment of the reasons for oral poliovirus vaccine refusals in northern Nigeria. J Infect Dis (2014) 210(Suppl. 1):S125–S130. 10.1093/infdis/jiu436
44.
SoofiSBVadsariaKMannanSHabibMATabassumFHussainI. Factors associated with vaccine refusal (Polio and Routine Immunization) in high-risk areas of Pakistan: a matched case-control study. Vaccines (Basel) (2023) 11(5):947. 10.3390/vaccines11050947
45.
Centers for Disease Control and Prevention. About the untreated syphilis study at Tuskegee (2024). Available online at: https://www.cdc.gov/tuskegee/about/index.html (Accessed July 30, 2025).
46.
PaolaFALaCivita NixonLWalkerR. Medical Ethics and Humanities. Burlington (MA): Jones & Bartlett Learning (2010).
47.
ShahS. CIA organised fake vaccination drive to get Osama bin Laden’s family DNA. The Guardian (2011). Available online at: https://www.theguardian.com/world/2011/jul/11/cia-fake-vaccinations-osama-bin-ladens-dna (Accessed July 24, 2026).
48.
Worldometer. Coronavirus in Iran. Available online at: https://www.worldometers.info/coronavirus/country/iran/ (Accessed July 30, 2025).
49.
GhafariMHosseinpourSRezaee-ZavarehMSDascaluSRostamianSArameshK. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran. BMC Med (2023) 21:429. 10.1186/s12916-023-03127-8
50.
TripathySKDasSMalikA. Vaccine and malnutrition: a narrative review. J Fam Med Prim Care (2023) 12:1808–13. 10.4103/jfmpc.jfmpc_596_23
51.
HoestCSeidmanJPanWAmbikapathiRKangGKosekM. Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges. Clin Infect Dis (2014) 59(Suppl. 4):S273–9. 10.1093/cid/ciu611
52.
PrendergastAJ. Malnutrition and vaccination in developing countries. Philos Trans R Soc Lond B Biol Sci (2015) 370:20140141. 10.1098/rstb.2014.0141
53.
JoiP. What impact does malnutrition have on the effectiveness of vaccination?Gavi (2020). Available online at: https://www.gavi.org/vaccineswork/what-impact-does- malnutrition-have-effectiveness-vaccination (Accessed July 24, 2025).
54.
ParkerEPKKampmannBKangGGrasslyNC. Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis. J Infect Dis (2014) 210:853–64. 10.1093/infdis/jiu182
55.
TaniuchiMPlatts-MillsJABegumSUddinMJSobuzSULiuJet alImpact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine (2016) 34:3068–75. 10.1016/j.vaccine.2016.04.080
56.
Our World in Data. Death Rate from Unsafe Water Sources. Available online at: https://ourworldindata.org/grapher/death-rates-unsafe-water (Accessed July 30, 2025).
57.
LimayeRJHolroydTABluntMJamisonAFSauerMWeeksRet alSocial media strategies to affect vaccine acceptance: a systematic literature review. Expert Review Vaccines (2021) 20:959–73. 10.1080/14760584.2021.1949292
58.
LeedomM. How climate change is changing vaccination planning. BMJ (2024):q360. 10.1136/bmj.q360
59.
JonesISadkiR. Climate change and immunisation: time to widen the scope?Gavi (2024). Available online at: https://www.gavi.org/vaccineswork/climate-change-and-immunisation-time-widen-scope (Accessed July 24, 2026).
60.
CarlsonCJ. Climate change increases cross-species viral transmission risk. Nature (2022) 607:555–62. 10.1038/s41586-022-04788-w
61.
KupferschmidtK. Feeling the heat. Science (2023) 381:1388–92. 10.1126/science.adl0412
62.
CarlsonCJCarletonTAOdoulamiRCMolitorCDTrisosCH. The historical fingerprint and future impact of climate change on childhood malaria in Africa. medRxiv [Preprint] (2023). 10.1101/2023.07.16.23292713v4
63.
VenkatesanP. Routine malaria vaccinations start in Africa. Lancet Microbe (2024) 5:e519. 10.1016/S2666-5247(24)00073-9
64.
KommendaNOsakaSDucroquetSPenneyV. Where dangerous heat is surging. The Wash Post (2024). Available online at: https://www.washingtonpost.com/climate-environment/interactive/2023/extreme-heat-wet-bulb-globe-temperature/ (Accessed July 24, 2026).
65.
MaloneyEDuffyD. Deciphering the relationship between temperature and immunity. Discov Immunol (2024) 3: kyae001. 10.1093/discim/kyae001
66.
SwaminathanALucasRHarleyDMcMichaelA. Will global climate change alter fundamental human immune reactivity: implications for child health?Children (2014) 1:403–23. 10.3390/children1030403
67.
AgacheIAkdisCAkdisMAl-HemoudAAnnesi-MaesanoMBalmesJet alImmune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation. Front Sci (2024) 2:1279192. 10.3389/fsci.2024.1279192
68.
World Health Organization. History of the smallpox vaccine (2024). Available online at: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-smallpox-vaccination (Accessed July 30, 2025).
69.
GlynnIGlynnJ. The Life and Death of Smallpox. London: Profile Books (2004).
70.
EveredEOEveredK. Mandating immunity in the Ottoman Empire: a history of public health education and compulsory vaccination. Heliyon (2020) 6(11):e05488. 10.1016/j.heliyon.2020.e05488
71.
FennerFHendersonDAAritaIJezekZLadnyiID. Smallpox and its Eradication. Geneva: World Health Organization (1988). Available online at: https://iris.who.int/handle/10665/39485 (Accessed July 30, 2025).
72.
HendersonDA. A history of eradication—successes, failures, and controversies. Lancet (2012) 379:884–5. 10.1098/rstb.2013.0113
73.
National Foundation for Infectious Diseases. The Triumph of Science: The Incredible Story of Smallpox Eradication (2023). Available online at: https://www.nfid.org/the-triumph-of-science-the-incredible-story-of-smallpox-eradication/ (Accessed July 30, 2025).
74.
ToppaS. Pakistan’s Secret Weapon Against Polio. Foreign Policy (2020). Available online at: https://foreignpolicy.com/2020/01/24/pakistan-polio-female-health-worker-religious-leaders-vaccinations/ (Accessed July 24, 2026).
75.
UNICEF. Closing the gap: the Afghan women gaining ground against vaccine refusals and zero dose children (2024). Available online at: https://www.unicef.org/afghanistan/stories/closing-gap-afghan-women-gaining-ground-against-vaccine-refusals-and-zero-dose-children (Accessed July 30, 2025).
76.
GAVI. Why integrating nutrition and immunisation can be a game-changer (2023). Available online at: https://www.gavi.org/vaccineswork/why-integrating-nutrition-and-immunisation-can-be-game-changer (Accessed July 30, 2025).
77.
World Food Program. State of school feeding worldwide 2022 (2023). Available online at: https://www.wfp.org/publications/state-school-feeding-worldwide-2022 (Accessed July 30, 2025).
78.
RitchieHVanderslottS. How Many People Support Vaccination Across the World?Oxford: Our World in Data (2019). Available online at: https://ourworldindata.org/support-for-vaccination (Accessed August 6, 2025).
79.
NazmunnaharABHaqueMATanbirMToknuzzamanASMSarkerR. COVID-19 vaccination success in Bangladesh: key strategies were prompt response, early drives for vaccines, and effective awareness campaigns. Health Sci Rep (2023) 6:e1281. 10.1002/hsr2.1281
80.
GAVI, The Vaccine Alliance. Bangladesh Zero-Dose Landscape. (2023) Available online at: https://zdlh.gavi.org/country-profiles/bangladesh (Accessed 2025 July 30).
81.
BaghiHBYousefiBOskoueeMAAghazadehM. HPV vaccinations: a Middle Eastern and North African dilemma. Lancet Infect Dis (2017) 17:18–9. 10.1016/S1473-3099(16)30553-9
82.
de MartelCPlummerMVignatJFranceschiS. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer (2017) 141:664–70. 10.1002/ijc.30716
83.
Our World in Data. Which countries include human papillomavirus (HPV) vaccines in their national vaccination programmes?Available online at: https://ourworldindata.org/grapher/human-papillomavirus-vaccine-immunization-schedule (Accessed July 30, 2025).
84.
World Health Organization. Human papillomavirus (HPV) vaccination coverage. Available online at: https://immunizationdata.who.int/global/wiise-detail-page/human-papillomavirus-(hpv)-vaccination-coverage (Accessed July 30, 2025).
85.
HamdiS. The impact of teachings on sexuality in Islam on HPV vaccine acceptability in the Middle East and North Africa region. J Epidemiol Glob Health (2018) 7:S17. 10.1016/j.jegh.2018.02.003
86.
MuhamadNBuangSJaafarSJaisRTanPSMustaphaNet alAchieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme. BMC Public Health (2018) 18:1402. 10.1186/s12889-018-6316-6
87.
World Health Organization. Uzbekistan achieves high HPV vaccination coverage against cervical cancer (2022). Available online at: https://www.who.int/europe/news-room/07-09-2022-uzbekistan-achieves-high-hpv-vaccination-coverage-against-cervical-cancer (Accessed July 30, 2025).
88.
UNICEF. Closing the gap: UNICEF bolsters country efforts to increase HPV vaccination (2023). Available online at: https://www.unicef.org/supply/stories/closing-gap-unicef-bolsters-country-efforts-increase-hpv-vaccination (Accessed July 30, 2025).
89.
Al KhaldiSTabcheCAtwanZRawafS. Knowledge and awareness of HPV vaccination uptake and recommendations in gulf cooperation council countries 2009–2025: a systematic review. Arch Public Health (2026) 84:81. 10.1186/s13690-026-01875-6
90.
AL-EitanLNAlmahdawiDLAbu KhiarahRAAlghamdiMA. Bridging gaps in vaccine access and equity: a Middle Eastern perspective. Vaccines (2025) 13(8):806. 10.3390/vaccines13080806
91.
MukherjeeSKalraKPhelanAL. Expanding global vaccine manufacturing capacity: strategic prioritization in small countries. PLOS Glob Public Health (2023) 3:e0002098. 10.1371/journal.pgph.0002098
92.
Population Matters. The facts and numbers. Available online at: https://populationmatters.org/the-facts-numbers/ (Accessed July 30, 2025).
93.
NdembiNKarunaSCowdenJCagigiAPilorgetAMoodleyAet alAccelerating vaccine development in Africa: lessons from HIV research. Lancet (2025) 405:1726–8. 10.1016/S0140-6736(25)00564-1
94.
DzauVBHatchettRBishenSKaseyaJBarbosaJFezouaF. The time for regionalised vaccine manufacturing has arrived. Lancet (2025) 405(10475):280–2. 10.1016/S0140-6736(25)00050-9
95.
World Health Organization. World Health Assembly adopts historic pandemic agreement to make the world more equitable and safer from future pandemics (2025). Available online at: https://www.who.int/news/item/20-05-2025-world-health-assembly-adopts-historic-pandemic-agreement-to-make-the-world-more-equitable-and-safer-from-future-pandemics (Accessed July 30, 2025).
96.
APET Secretariat. Effective Delivery of Vaccines in Africa Using Drone Technology. AUDA-NEPAD (2023). Available online at: https://www.nepad.org/blog/effective-delivery-of-vaccines-africa-using-drone-technology (Accessed July 24, 2026).
97.
YimerS. Hope from the sky: drones deliver vaccines to remote regions of Ethiopia. Gavi VaccinesWork (2024). Available online at: https://www.gavi.org/vaccineswork/hope-sky-drones-deliver-vaccines-remote-regions-ethiopia (Accessed July 24, 2026).
98.
World Health Organization. INDIA: a push to vaccinate every child, everywhere, ended polio in India (2021). Available online at: https://www.gavi.org/vaccineswork/hope-sky-drones-deliver-vaccines-remote-regions-ethiopia (Accessed July 30, 2025).
Summary
Keywords
climate change, Islamic countries, vaccine access, vaccine hesitancy, vaccines
Citation
Roberts A-O and Jameel S (2026) Vaccination in Islamic countries: a narrative review. Public Health Rev. 47:1609007. doi: 10.3389/phrs.2026.1609007
Received
22 August 2025
Revised
04 July 2026
Accepted
17 July 2026
Published
04 August 2026
Volume
47 - 2026
Edited by
Katarzyna Czabanowska, Maastricht University, Netherlands
Reviewed by
Mohammad Khalid, Linköping University Hospital, Sweden
One reviewer who chose to remain anonymous
Updates
Copyright
© 2026 Roberts and Jameel.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. PHR is edited by the Swiss School of Public Health (SSPH+) in a partnership with the Association of Schools of Public Health of the European Region (ASPHER)+
*Correspondence: Shahid Jameel, shahid.jameel@oxcis.ac.uk
† Present address: Antonia-Olivia Roberts, Imperial College Healthcare NHS Trust, Faculty of Medicine, Imperial College London London, United Kingdom
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.